Board of Directors

George F.J. Gosbee is the chair of Arcadia’s board of directors and has served as a director since May 2015. He is the chairman and CEO of AltaCorp Capital. Prior to founding AltaCorp Capital in 2010, Mr. Gosbee was chairman, president and CEO of Tristone Capital Global Inc., a global energy investment firm that was acquired by an international bank in 2009. Mr. Gosbee is an alternate governor on the NHL Board of Governors and co-owner of the Arizona Coyotes. Mr. Gosbee was the vice chairman of Alberta Investment Management Co (AIMCo) which is a $90 billion institutional investment fund, and currently is a director. Mr. Gosbee is a former director of the TMX Group and a former board member of Chrysler Group LLC in Detroit, where he served on behalf of both the Canadian Federal and Provincial (Ontario) governments to oversee their collective investment in the company and assist in the restructuring. He holds a bachelor of commerce degree from the University of Calgary.

Kevin Comcowich joined the Arcadia board in October 2016. Mr. Comcowich brings extensive business and financial leadership experience and a proven track record of success in investment management and global capital market strategies. He most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He was previously the president and chief investment officer (CIO) of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners fund. Mr. Comcowich received his MBA from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross.

Uday Garg has been a director of Arcadia since June 2014. Mr. Garg is the founder of Mandala Capital, a private equity fund, and has served as managing director and a director since its inception in 2008. Previously, he was a portfolio manager at Duet Group, Altima Partners and Amaranth Advisors, and began his career as an investment banker with Deutsche Bank. Mr. Garg holds a bachelor’s degree in economics with a concentration in finance from the Wharton School of Business at the University of Pennsylvania.

Raj Ketkar became a member of the board of directors in June 2016, after joining the company as president and chief executive officer in May 2016. He brings nearly 35 years of agriculture and agricultural biotechnology business experience in the U.S. and internationally, including more than 30 years in a variety of business, operations, and strategy roles for Monsanto Company. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a master’s of business administration from the University of New Orleans.

Eric J. Rey joined the board of directors in June 2017. He is one of the founders of Arcadia Biosciences and served as president and CEO, as well as a director, until 2016. Prior to founding Arcadia, Mr. Rey was a partner with Rockridge Group, a management consulting firm for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop and industrial products. He previously served as vice president of operations with Calgene, Inc., including two years with Monsanto Company following its acquisition of Calgene. Mr. Rey has a bachelor’s degree in plant science from the University of California, Davis. He currently serves as a director for Phytelligence, Inc. and Texas Crop Science, LLC.

Gregory D. Waller joined Arcadia’s board of directors in June 2017. He is the former chief financial officer (CFO) of Ulthera Corporation, a privately-held company providing ultrasound technology for aesthetic and medical applications, which was acquired by Merz North America in 2014. Previously, Mr. Waller was CFO of Universal Building Products and Sybron Dental Specialties, Inc., and vice president and treasurer of Kerr, Ormco Corporation, and Metrex. Mr. Waller has an MBA with a concentration in accounting from California State University, Fullerton. He has extensive experience serving on the boards of public companies and currently serves as a director for Sunshine Heart and Endologix Corporation.